Document is current
Any future updates will be listed below
-
Authors
Hossenbaccus, Lubnaa
Linton, Sophia
Garvey, Sarah
Botting, Hannah
Walker, Terry
Steacy, Lisa
Ellis, Anne K.
- License Information
-
More Information
Article History
Received: 25 March 2025
Accepted: 2 July 2025
First Online: 6 August 2025
Declarations
:
: The protocol for this study was reviewed and ethical approval was provided by the Queen’s University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board.
: No applicable.
: In the past 3 years, Dr. Anne K. Ellis has participant in advisory boards for Agence Unik, ALK Abello A/S, AstraZeneca, Celltrion Pharmaceuticals, GSK, HAL Allergy Group, Medexus Pharmaceuticals, Miravo Healthcare, Novartis Pharmaceuticals, and Sanofi-Opella Healthcare and has been a speaker for ALK Abello A/S, AstraZeneca, COVIS Pharma, GSK, Medexus Pharmaceuticals, Novartis Pharmaceuticals, Regeneron Pharmaceuticals Inc, and Sanofi-Aventis Canada. Her institution has received research grants from ALK Abello A/S, AstraZeneca, Bayer Consumer Health, Merck Canada, Novartis Pharmaceuticals, Regeneron Pharmaceuticals Inc., Sanofi-Aventis Canada, and Sanofi-Opella Healthcare. She has served as an independent consultant to Bayer Consumer Health, Orexo, Regeneron Pharmaceuticals Inc, and Takeda Pharmaceuticals. The other authors have nothing to declare.
